Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Photrex PDT for AMD
NCT00157976Phase 3Unknown
- Sponsor
- Miravant Medical Technologies
- Start
- Sep 2005
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 4
01
Overview
A Phase 3 trial of Rostaporfin in age-related macular degeneration (AMD), sponsored by Miravant Medical Technologies. Status: unknown.
02
Drugs
Rostaporfin
03
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on NCT00157976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00157976.